Avantor Filed for a $100 million IPO on 3/15/19. The stock will trade on the NYSE under the symbol AVTR.
Avantor provides products and services to biopharma, nutraceutical, biomaterials... read more
Avantor Filed for a $100 million IPO on 3/15/19. The stock will trade on the NYSE under the symbol AVTR.
Avantor provides products and services to biopharma, nutraceutical, biomaterials... read more
Proteon Therapeutics, a clinical-stage company focused on first-in-class therapeutics that meaningfully improve the lives of patients with kidney and vascular diseases has filed for a $50 million... read more
On 3/13/19 Deerfield Management announced plans to invest $100 million in translational life science research at Harvard. Harvard University and Deerfield Management, a healthcare investment firm... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,